St George Mining Ltd (ASX:SGQ, FRA:S0G, OTC:SGQMF) has secured firm commitments to raise A$60 million, strengthening its balance sheet as it advances the high-grade Araxá rare earths and niobium project in Minas Gerais, Brazil.
The company will raise the funds through a two-tranche institutional placement of 600 million new fully paid ordinary shares priced at A$0.10 per share.
The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points.
The index has gained 4.36% over the past five days, adding 148.50 points as small-cap investor sentiment continues to firm. It has been a quiet start to the day for news releases, but you can read about the following and more throughout the day.
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has completed the manufacture of a new batch of HMBD-002, its VISTA-targeting monoclonal antibody cancer drug candidate, keeping the company on track to prepare clinical trial material for a planned new study in the second half of CY2026.
The Melbourne-based biotechnology company received a Certificate of Analysis for the newly manufactured HMBD-002 batch, with all product quality attributes reported to be within expected limits.
Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) said it has signed an exclusive commercial licence agreement with Max-Planck-Innovation GmbH, giving the company long-term global rights to intellectual property covering nano-encapsulated sulfur cathode technology and novel nano-confined anode materials.
The AIM-listed sulfur battery developer said the deal follows a March 2025 collaboration agreement, under which Gelion had secured an exclusive option to acquire commercial rights to the technology.
There's relief for mortgage holders this month, after the Reserve Bank of Australia left the official cash rate unchanged at 4.35%, pausing after three consecutive increases this year. It;s not a full sigh of relief, though, with the regulator signalling it remains prepared to tighten policy further if inflation does not continue moving back toward target.
Tuesday's decision was unanimous and widely expected by markets, with the RBA opting to assess the impact of its earlier rate hikes and recent disruption to global oil supplies.
Dimerix Ltd (ASX:DXB, OTC:SBMJF) has entered into an exclusive licence agreement with Everest Medicines for the commercialisation of its Phase 3 drug candidate DMX-200 across Greater China, South Korea and parts of Southeast Asia.
The agreement covers DMX-200 for all indications, including focal segmental glomerulosclerosis (FSGS), in Chinese mainland, Hong Kong SAR, Macao SAR, Taiwan region, South Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam and the Philippines.
Memphasys Ltd (ASX:MEM, OTC:MPHSF, FRA:IG7) has executed a 12-month exclusive national supply agreement with Monash IVF Group Ltd (ASX:MVF) (ASX) for the rollout of its Felix™ automated sperm selection system across Australia.
The agreement follows more than 10 years of collaboration between the companies and comes after Monash IVF conducted the pivotal Felix clinical trial, which concluded in 2025.
Swoop Holdings Ltd (ASX:SWP) has entered into a mobile wholesale partnership with TPG Telecom Ltd (ASX:TPM), strengthening the company’s mobile offering through its Moose Mobile subsidiary.
The Mobile Virtual Network Operator (MVNO) wholesale agreement, effective June 16, 2026, gives Moose Mobile access to TPG’s national mobile network on a wholesale basis.
Atomic Eagle Ltd (ASX:AEU) has expanded known uranium mineralisation at the Chisebuka deposit within its 100%-owned Muntanga Uranium Project in Zambia, with drilling continuing to extend higher-grade zones beyond the existing resource boundary.
The company reported new resource extension drilling results from Chisebuka, including:
Amara Minerals is raising about $2.2 million via a share placement, with funds to support ongoing drilling at its Lauriston and Apollo gold-antimony projects in Victoria.
The placement will comprise about 440 million fully paid ordinary shares priced at $0.005 per share, representing a 25% premium to the company’s last traded price of $0.004 on 11 June 2026.
Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) (ASX: COB, OTC: CBBHF) and Glomar Minerals LLC have advanced plans for Project Infinity, a proposed polymetallic nodule refinery in the United States.
The consortium, formed in March 2026, aims to build and operate what it says would be the world’s first commercial polymetallic nodule refinery in the US, targeting production of manganese, cobalt, nickel and copper from deep-sea nodules.
BOA Resources Ltd (ASX:BOA) has reached a key permitting milestone at the Neds Creek Copper Project in Western Australia’s Murchison region, with the Department of Mines, Petroleum and Exploration commencing the grant of the project tenements.
Seven of 14 tenement applications have now been granted, representing 64% of the total project area. Importantly, the two tenements covering proposed drilling are among those now granted, with the balance expected to follow in the near future.
Critical Resources Ltd (ASX:CRR, FRA:9S70) has attained a manufacturing milestone in its solid-state battery evaluation program, depositing a complete cathode, solid electrolyte and conductive network in a single dry step.
The work demonstrated a streamlined pathway for solid-state lithium-ion battery production without solvents, binders, drying ovens or furnaces - processes that are typically among the most energy and capital-intensive parts of battery manufacturing.
Aruma Resources Ltd (ASX:AAJ) has strengthened its exploration model at the Tillex Copper-Silver Project in Ontario, Canada, after downhole electromagnetic surveys confirmed a strong conductor extending along strike and at depth.
The results provide the company with more clearly defined targets ahead of Phase 2 drilling and support its view that Tillex could host a larger, continuous copper-silver system than previously understood.